The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Possible clinical implication of serum testosterone surge caused by the GnRH antagonist degarelix.
Gaku Arai
No relevant relationships to disclose
Kojiro Nishio
No relevant relationships to disclose
Ryo Sato
No relevant relationships to disclose
Makoto Kawaguchi
No relevant relationships to disclose
Keisuke Suzuki
No relevant relationships to disclose
Toshiyuki Iwahata
No relevant relationships to disclose
Yuko Sadaoka
No relevant relationships to disclose
Shigeyuki Ota
No relevant relationships to disclose
Masashi Iijima
No relevant relationships to disclose
Takeshi Shin
No relevant relationships to disclose
Yoshio Ashizawa
No relevant relationships to disclose
Yoshitomo Kobori
No relevant relationships to disclose
Hiroshi Yagi
No relevant relationships to disclose
Shigehiro Soh
No relevant relationships to disclose
Hiroshi Okada
No relevant relationships to disclose